Dermatological Therapeutics

Global Markets

Publication Date	January 2009
Publisher	BCC Research
Product Type	Report
Pages	199
ISBN Number	not applicable
Product Code	BCC00264

Buy this product or for assistance call +44 20 7060 7474

PDF £2,915.00$4849 | €3263

PRINT £2,915.00$4849 | €3263

FAX Order above formats by FAX

Summary

The skin is the largest organ of the human body. Apart from protecting and providing sensation, it performs important functions such as heat regulation and excretion. Skin is the body's first line of defense against a hostile environment, being waterproof from both directions and germ-proof.

There are about two square meters of skin covering an average adult and it accounts for about an eighth of the total body weight. Apart from clinical diagnosis, there are few methods for diagnosing skin disorders. Treatment options include combinations of prescription drugs, surgery, phototherapy, chemical peels, cryotherapy, radiotherapy, chemotherapy and others.

This BCC Research report offers a comprehensive picture of trends in the global dermatological therapeutics industry through 2007, and makes market projections over a 5-year period, from 2008 to the end of 2013. It covers five categories of prescriptions drugs including anti-infective, anti-acne, anti-psoriasis, corticosteroid and other dermatological drugs, which includes topical treatments.

The impact of the governmental regulatory environment is examined in detail. Established market segments are analyzed by skin disorder and type of treatment. Emerging technologies in permeation enhancement, in plasma skin regeneration, and in treatment of various disorders such as dermatitis, acne and radiotherapy are discussed. Analysis of industry structure is also included.

The scope of this report is broad and includes:

Descriptions of the major types of skin disorders including acne, bacterial, fungal, viral, parasitic, cancerous, cornification, bullous, dermatitis-related, psoriasis-related, hypersensitivity-related, pigmentation-related, sweating-related and many others
The current global market status for dermatological therapeutics, with trends and forecasts for growth over the next 5 years
Discussion of various types of skin cancer, including types of melanoma, and available treatments
Analysis of common diagnostic procedures including dermoscopy, patch testing, skin biopsy, cultures and phototests
Company profiles

Report Highlights:

The global dermatological therapeutics market was worth an estimated $25.0 billion in 2008. This should reach $38.0 million in 2013, for compound annual growth rate (CAGR) of 8.7%.
Anti-infective dermatological drugs generated an estimated $8.0 billion in 2008. This is expected to grow at a CAGR of 4.6% to reach $10.0 billion in 2013.
Topical and other types of dermatological drugs generated an estimated $6.3 billion in 2008. This segment should increase to $11.0 billion in 2013, for a CAGR of 12.0%.

Content

Chapter One: Introduction
- Study Goals And Objectives
- Reasons For Doing This Study
- Intended Audience
- Scope Of Report
- Methodology
- Information Sources
- About The Author
- Related Bcc Research Reports
- Bcc Online Services
- Disclaimer

Chapter Two: Summary
- Summary Table Global Dermatological Therapeutics Revenue Forecast By Market Segment, Through 2013 ($ Billions)
- Summary Figure Global Dermatological Therapeutics Revenue Forecast By Market Segment, 2008 And 2013 (%)

Chapter Three: Overview
- Human Skin
- Skin Disorders
- Acne
- Rosacea
- Bacterial Infections Of The Skin
- Benign Skin Growths Or Tumors
- Bullous Disorders Or Blistering Diseases
- Skin Cancers
- Types Of Melanoma
- Lentigo Maligna Melanoma
- Superficial Spreading Melanoma
- Nodular Melanoma
- Acral-Lentiginous Melanoma
- Cornification Disorders
- Calluses And Corns
- Ichthyosis Or Dry Skin
- Keratosis Pilaris
- Sebaceous Cysts
- Dermatitis
- Fungal Infections Of The Skin
- Hypersensitivity And Inflammatory Disorders
- Acute Febrile Neutrophilic Dermatosis (Sweets Syndrome)
- Drug Eruptions And Reactions
- Erythema Multiforme
- Erythema Nodosum
- Granuloma Annulare
- Panniculitis
- Pyoderma Gangrenosum
- Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis
- Bed Sore
- Pityriasis Rosea
- Parasitic Infections Of The Skin
- Psoriasis And Scaling Diseases
- Psoriasis Treatment
- Pigmentation Disorders
- Birthmarks
- Poison Ivy
- Reactions To Sunlight
- Aging
- Actinic Keratoses
- Skin Cancers
- Photosensitivity
- Sunburn
- Sweating Disorders
- Viral Skin Diseases
- Common Diagnostic Tests For Skin Disorders
- Dermoscopy
- Patch Testing
- Skin Biopsy
- Culture
- Phototests
- Morbidity/Prevalence
- Therapeutic Procedures For The Skin
- Cancer Surgery
- Excisional Biopsy To Remove Skin Cancer
- Curettage And Electrocautery
- Mohs Micrographic Surgery (Mms)
- Wide Local Excision
- Skin Grafting
- Lymph Node Removal
- Chemical Peels
- Cryotherapy/Cryosurgery
- Ice Packs
- Cold Gel Packs
- Ice Immersion
- Ice Massage
- Vapocoolant Sprays
- Radiotherapy
- Chemotherapy
- Chemotherapy Creams
- Chemotherapy Into A Vein
- Laser Surgery
- Carbon Dioxide Laser
- Yag Laser
- Pulsed Dye Laser Or Argon Laser
- Excimer Laser
- Photodynamic Therapy
- Application In Dermatology
- Goeckerman Treatment
- Puva
- Ultraviolet B Phototherapy
- Broadband
- Narrowband
- Sclerotherapy

Chapter Four: Prescription Dermatological Drugs
- Systemic Drugs
- Acitretin
- Clindamycin
- Erythromycin
- Cyclosporine
- Methotrexate
- Thalidomide
- Systemic Antibacterial Agents
- Antileprotic Drugs (Including Dapsone)
- Antimalarial Drugs (Including Hydroxychloroquine)
- Systemic Antifungal Agents
- Systemic Antihistamines
- Systemic Antiparasitic Agents
- Systemic Antipruritic Agents
- Systemic Antiviral Agents
- Systemic Corticosteroids
- Systemic Interferons
- Systemic Retinoid
- Other Systemic Drugs
- 6-Thioguanine
- Hydroxyurea
- Mycophenolate Mofetil
- Sulfasalazine
- Biological Therapies (Biologics)
- Colchicine
- Cytotoxic And Immunosuppressive Drugs
- Retinoids
- Hormones And Anti-Androgens
- Hormones And (Continued)
- Topical Treatments
- Aciclovir
- Topical Retinoids
- Anthralin
- Coal Tar
- Corticosteroids
- Retinoid: Tazarotene
- Vitamin D3: Calcipotriene
- Capsaicin
- Topical Medications In Clinical Trials
- Moisturizers And Scale Removers

Chapter Five: Technology Review
- Emerging Technologies In Dermatology
- Dna Microarray Technology In Dermatology
- Advances In The Treatment Of Varicose Veins
- Emerging Treatment Of Atopic Dermatitis
- Emerging Drugs For Ichthyosis
- Progress In The Management Of Acne
- Plasma Skin Regeneration Technology
- Permeation Enhancement Technologies
- Drug Permeation Enhancement Via Buccal Route
- Thiomatrix: Permeation Enhancement
- Merrions Technology: Gastrointestinal Permeation Enhancement Technology (Gipet)
- Transdermal Protein Delivery Or Measurement Using Low-Frequency Sonophoresis
- Radiotherapy
- External Radiotherapy
- Conformal Radiotherapy
- Intensity Modulated Radiotherapy
- Internal Radiotherapy
- Radioactive Implants
- Radioactive Liquids
- Plasma Skin Regeneration

Chapter Six: Patent Analysis
- Patent Issue Trends In United States
- Patent Issue Trends In Europe

Chapter Seven: Industry Participant Profiles
- Manufacturers Of Dermatological Drugs
- Agi Dermatics
- Allergan, Inc
- Amgen, Inc
- Anacor Pharmaceuticals
- Anika Therapeutics, Inc
- Astellas Us, Llc
- Chester Valley Pharmaceuticals, Inc
- Coria Laboratories, Ltd
- Coria Laboratories, Ltd
- Dermik Laboratories, Inc
- Dusa Pharmaceuticals, Inc.
- Eisai, Inc.
- Ferndale Laboratories, Inc.
- Galderma Laboratories
- Genentech, Inc.
- Isolagen, Inc.
- Leo Pharma A/S
- Medicis Pharmaceutical Corp
- Medimetriks Pharmaceuticals, Inc.
- Merz Pharma Uk, Ltd.
- Neosil, Inc.
- Nycomed U.S., Inc.
- Obagi Medical Products, Inc.
- Onset Therapeutics
- Orthoneutrogena
- Pierre Fabre Pharmaceuticals, Inc
- Prime Pharmaceuticals Corp
- Qlt, Inc.
- Quinnova Pharmaceuticals
- Schering-Plough Corp
- Sinclair Pharmaceuticals
- Skinmedica, Inc.
- Stiefel Laboratories, Inc.
- Summers Laboratories, Inc
- Syntopix Group, Plc
- Triax Pharmaceuticals, Llc
- Valeant Pharmaceuticals International
- Valeo Pharma, Inc.
- Warner Chilcott, Ltd
- Xoma, Ltd
- Non-Commercial Organizations
- African Association Of Dermatology
- American Academy Of Dermatology (Aad)
- American Behcets Disease Assoc., Inc
- American Celiac Society
- American Hemochromatosis Society, Inc
- American Lupus Society
- American Skin Association, Inc
- American Social Health Assoc
- Arthritis Foundation
- Asian Dermatological Association
- Association Of Professors Of Dermatology
- Ataxia-Telangiectasia Childrens Project
- Basal Cell Carcinoma Nevus Syndrome/Gorlin Syndrome
- Bay Area Lupus Foundation
- Blooms Syndrome Registry
- British Association Of Dermatologists
- Celiac Disease Foundation
- Celiac Sprue Association/Usa
- Cicatricial Alopecia Research Foundation
- Coalition Of Skin Diseases
- Cornelia De Lange Syndrome Foundation, Inc
- Cutaneous Lymphoma Foundation
- Dermatology Foundation
- Dermatology Nurses Association (Dna)
- Dermatopathology Foundation
- Dysautonomia Foundation, Inc
- Dystrophic Epidermolysis Bullosa
- The Ectodermal Dysplasia Society
- Ehlers Danlos National Foundation (Ednf)
- Ehlers-Danlos Syndrome Foundation
- European Academy For Dermatology And Venereology
- Eadv Administrative Office
- The European Dermatology Forum
- European Society For Dermatological Research
- European Union Of Medical Specialists
- Foundation For Ichthyosis And Related Skin Types (F.I.R.S.T.)
- Gluten Intolerance Group (Dermatitis Herpetiformis)
- Hemochromatosis Research Foundation
- Hidradenitis Suppurativa Foundation, Inc
- Histiocytosis Association Of America
- Inflammatory Skin Disease Institute (Isdi)
- International Foundation For Dermatology
- The International League Of Dermatological Societies Office
- International Pemphigus Pemphigoid Foundation
- The International Society Of Dermatopathology
- Klippel-Trenaunay Support Group
- Lupus Foundation Of America, Inc.
- Lymphoma Research Foundation
- Lymphomatoid Papulosis Central Registry
- Marfan Assoc. U.K.
- The Melanoma Research Foundation
- Muscular Dystrophy Assoc
- Myositis Association Of America (Maa)
- National Alopecia Areata Foundation (Naaf)
- National Ataxia Foundation
- National Eczema Association (Nea)
- National Eczema Association For Science And Education
- National Eczema Society
- National Epidermolysis Bullosa Registry
- National Foundation For Ectodermal Dysplasias
- National Foundation For Vitiligo And Pigment Disorders
- National Inconitentia Pigmenti Foundation
- National Medical Assoc
- National Neurofibromatosis Foundation
- National Organization For Albinism And Hypopigmentation (Noah)
- National Organization For Rare Disorders (Nord)
- The National Pemphigus Foundation
- National Psoriasis Foundation
- National Registry For Ichthyosis And Related Disorders
- National Vitiligo Foundation
- Nevoid Basal Cell Carcinoma Syndrome Support Network
- Pachyonychia Congenita Project
- The Psoriasis Assoc.
- Scleroderma Federation, Inc
- Scleroderma Foundation
- Scleroderma Research Foundation
- The Scleroderma Society
- Society For Investigative Dermatology (Sid)
- Society For Pediatric Dermatology (Spd)
- The Sturge-Weber Foundation
- The Vitiligo Society, U.K.
- Vitiligo Support International
- Vzv Research Foundation
- Xeroderma Pigmentosum Society
- Strategic Alliances In The Dermatology Market
- Mergers & Acquisitions
- Venture Capital Deals

Chapter Eight: Regulatory Preview
- Drug Regulation In The United States
- Licenses For Medical Devices
- Drug Regulation In The United Kingdom
- Licenses For Drugs
- Drug And Equipment Approval In Europe
- Licenses For Medical Equipment
- Reimbursement For Dermatological Treatment
- Reimbursement In The United States
- Reimbursement In Europe

Chapter Nine: Market Metrics
- Market Trends
- Big Pharmas Focus On Blockbuster Drugs Enables Specialty Focus By Small And Medium-Sized Firms
- Cosmetic/Aesthetic Dermatology Faces Downturn
- Changes In Reimbursement And Other Legislation Are Creating Uncertainty
- Managed Care Issues
- Medical Liability
- Physician Quality Reporting Initiative (Pqri)
- Dermatologic Surgery
- Cosmetic Procedure Tax
- Increased Use Of Generics In Prescription Dermatology
- Difficulties In Determination Of Bioavailability Of Topical Drugs
- Physician Shortage And Paramedic Influx In Dermatology
- Certification Exam For Nurse Practitioners In Dermatology Now Available
- Use Of Procedure-Therapy And Specific Drugs In Dermatology
- Pollution Contributes To Rise In Atopic Dermatitis
- Manufacturers Of Tnf-Blocker Drugs Ordered To Highlight Risk Of Fungal Infections
- Higher Co-Pays For Biologics Impacts Prescriptions
- U.S. Dermatological Market
- Prescription Data For Acne
- Enbrel
- Botox
- Loceryl
- Global Dermatological Therapeutics Market

List Of Tables
- Summary Table Global Dermatological Therapeutics Revenue Forecast By Market Segment, Through 2013 ($ Billions)
- Table 1 Functions Of The Skin
- Table 2 Disorders Of The Skin
- Table 3 Types Of Acne
- Table 4 Types Of Rosacea
- Table 5 Drugs And Their Action Against Acne And Rosacea
- Table 6 Types Of Bacterial Infections Of The Skin
- Table 7 Some Prescription Drugs Prescribed To Treat Bacterial Skin Infections
- Table 8 Types Of Benign Skin Growths Or Tumors
- Table 9 Some Prescription Drugs Used To Treat Benign Skin Growths
- Table 10 Types Of Bullous Disorders
- Table 11 Some Prescription Drugs Used To Treat Bullous Skin Disorders
- Table 12 Types Of Skin Cancers
- Table 13 Skin Cancer Incidence In The U.S.
- Table 14 Some Prescription Drugs Used To Treat Cutaneous Carcinomas
- Table 15 Types Of Calluses And Corns
- Table 16 Types Of Ichthyosis
- Table 17 Types Of Keratosis Pilaris
- Table 18 Types Of Dermatitis
- Table 19 Some Drugs Prescribed For Dermatitis
- Table 20 Types Of Fungal Infections Of The Skin
- Table 21 Some Drugs Prescribed To Treat Fungal Infections Of The Skin
- Table 22 Types Of Drug Reactions And Typical Causative Agents
- Table 23 Types Of Erythema Multiforme
- Table 24 Some Drugs Prescribed To Treat Hypersensitivity And Inflammatory Disorders
- Table 25 Types Of Parasitic Infection Of The Skin
- Table 26 Some Drugs Prescribed To Treat Parasitic Infections Of The Skin
- Table 27 Types Of Psoriasis And Scaling Diseases
- Table 28 Types Of Pigmentation Disorders
- Table 29 Some Prescription Drugs For Pigmentation Disorders
- Table 30 Types Of Photosensitivity
- Table 31 Types Of Sweating Disorders
- Table 32 Types Of Viral Skin Diseases
- Table 33 Some Drugs Prescribed To Treat Viral Diseases Of The Skin
- Table 34 Skin Disorder Morbidity In The U.S. By Age And Cause (Thousands)
- Table 35 Skin Conditions Requiring Only Laser Surgery
- Table 36 Advantages And Disadvantages Of Excimer Laser
- Table 37 Various Cancers Treatable By Pdt
- Table 38 Various Skin Disorders Treatable By Pdt
- Table 39 Advantages And Disadvantages Of Uvb Therapy
- Table 40 Advantages And Disadvantages Of Cyclosporine
- Table 41 Advantages And Disadvantages Of Methotrexate
- Table 42 Advantages And Disadvantages Of Anthralin
- Table 43 Advantages And Disadvantages Of Coal Tar
- Table 44 Advantages And Disadvantages Of Corticosteroids
- Table 45 Topical Corticosteroids, 2004
- Table 46 Advantages And Disadvantages Of Tazarotene
- Table 47 Advantages And Disadvantages Of Calcipotriol
- Table 48 Drug Treatments For Skin Disease Introduced In 2006
- Table 49 New Technologies In Dermatology
- Table 50 Number Of U.S. Patents Issued, 2003 To July 31, 2008
- Table 51 Companies And Number Of U.S. Patents Filed By Them, 2003 To July 31, 2008
- Table 52 Recent Dermatology U.S. Patents
- Table 53 European Dermatological Patents, 2003-July 2008
- Table 54 Recent Patents Issued By The Epo
- Table 55 Dermatological Associations
- Table 56 Significant Mergers And Acquisitions (2005-2008)
- Table 57 Leading Drugs Prescribed By Office-Based Dermatologistsall Indications, 2008 (Thousands)
- Table 58 U.S. Dermatological Therapeutics Market: Revenue Forecast By Market Segment, Through 2013 ($ Billions)
- Table 59 Market Share Of Prescription Drug Manufacturers, 2005-2007 ($ Millions)
- Table 60 Global Dermatological Therapeutics Revenue Forecast By Market Segment, Through 2013

List Of Figures
- Summary Figure Global Dermatological Therapeutics Revenue Forecast By Market Segment, 2008 And 2013 (%)
- Figure 1 Gastrointestinal Permeation Enhancement Technology
- Figure 2 U.S. Patent Trends, 1990-2001
- Figure 3 Prescribing Of Oral Antibiotics For The Intitial Treatment Of Acne: Current And In 1 Year (N=75)
- Figure 4 Prescribing Of Topical Antibiotics/Retinoids For Acne: Current And In 1 Year (N=75)
- Figure 5 Share Of Segments In U.S. Prescription Dermatology Market, 2008 And 2013 (%)
- Figure 6 Leading Prescription Drug Revenues In Global Dermatology Market, 2008 ($ Millions)
- Figure 7 Enbrel Sales In Global Dermatology Market By Geography, 2008 (%, Total Revenue = $ 3,230 Million)
- Figure 8 Botox Sales In The Global Dermatology Market By Geography, 2008 (%, Total Revenue = $ 1,200 Million
- Figure 9 Loceryl Sales In Global Dermatology Market By Geography, 2008 (%, Total = $350 Million
- Figure 10 Global Dermatological Prescription Market By Regional Sharefuture Outlook, 2011 (%)
- Figure 11 Global Dermatological Market By Regional Share, 2008 (%)
- Figure 12 Global Prescription Dermatology Market Share By Segment, 2008 (%)